COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804

Article view: 784

Article download: 201

IP Indian Journal of Immunology and Respiratory Medicine


Glycosylated hemoglobin (HbA1C): A brief overview for clinicians


Full Text PDF Share on Facebook Share on Twitter


Author Details : Gautam Rawal, Sankalp Yadav, Raj Kumar, Amrita Singh

Volume : 1, Issue : 2, Year : 2016

Article Page : 33-36


Suggest article by email

Abstract

Glycosylated hemoglobin (HbA1c) is an index of estimated average blood glucose over the preceding three months, giving an estimate of long-term glycemic status. Its value is used both for the diagnosis and monitoring the blood glucose control of the patients with diabetes mellitus. Though a widely used tool the value of HbA1c is influenced by various factors which, if not kept in mind of the treating clinician may lead to a false diagnosis or false sense of diabetic control. The authors give a brief overview of the HbA1c and the factors affecting its value.

Keywords:
Diabetes mellitus; Estimated average glucose; Glycosylated hemoglobin; Glycemic control

How to cite : Rawal G, Yadav S, Kumar R, Singh A, Glycosylated hemoglobin (HbA1C): A brief overview for clinicians. IP Indian J Immunol Respir Med 2016;1(2):33-36

Copyright © 2016 by author(s) and IP Indian J Immunol Respir Med. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (creativecommons.org)